We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+12.27%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$456M
AUM Growth
+$68.2M
Cap. Flow
+$32.6M
Cap. Flow %
7.15%
Top 10 Hldgs %
36.84%
Holding
146
New
10
Increased
59
Reduced
35
Closed
4

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$16.1M
2
EBAY icon
eBay
EBAY
+$5.35M
3
CRL icon
Charles River Laboratories
CRL
+$1.55M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.45M
5
COP icon
ConocoPhillips
COP
+$1.16M

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Consumer Discretionary 20.22%
3 Financials 12.39%
4 Healthcare 11.49%
5 Industrials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
51
Colgate-Palmolive
CL
$73.1B
$2.63M 0.58%
30,854
+285
+0.9% +$22.3K
AIG icon
52
American International
AIG
$41.7B
$2.56M 0.56%
44,950
-2,400
-5% -$137K
MSGS icon
53
Madison Square Garden
MSGS
$9.48B
$2.46M 0.54%
14,175
+500
+4% +$90.8K
MRK icon
54
Merck
MRK
$322B
$2.44M 0.53%
31,782
-1,275
-4% -$102K
TXN icon
55
Texas Instruments
TXN
$252B
$2.4M 0.53%
12,745
-400
-3% -$76.8K
IBM icon
56
IBM
IBM
$211B
$2.37M 0.52%
17,695
-2,383
-12% -$299K
SIVB
57
DELISTED
SVB Financial Group
SIVB
$2.29M 0.5%
3,371
EMR icon
58
Emerson Electric
EMR
$83.9B
$2.25M 0.49%
24,147
-1,700
-7% -$160K
FISV
59
Fiserv Inc
FISV
$28.8B
$2.23M 0.49%
21,435
+2,525
+13% +$261K
NVS icon
60
Novartis
NVS
$297B
$2.18M 0.48%
24,960
+400
+2% +$33.2K
MKC icon
61
McCormick & Company Non-Voting
MKC
$13.7B
$2.11M 0.46%
21,880
+200
+0.9% +$17K
DIS icon
62
Walt Disney
DIS
$167B
$2.02M 0.44%
13,018
-525
-4% -$84.8K
PFE icon
63
Pfizer
PFE
$143B
$1.8M 0.4%
30,559
+600
+2% +$29.7K
BDX icon
64
Becton Dickinson
BDX
$45.6B
$1.72M 0.38%
7,005
+461
+7% +$110K
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$121B
$1.63M 0.36%
+7,440
New +$1.45M
CRL icon
66
Charles River Laboratories
CRL
$11.2B
$1.5M 0.33%
+3,995
New +$1.55M
INFL icon
67
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
$1.49M 0.33%
47,675
+7,750
+19% +$239K
COP icon
68
ConocoPhillips
COP
$147B
$1.41M 0.31%
19,587
+15,976
+442% +$1.16M
CSGP icon
69
CoStar Group
CSGP
$11.7B
$1.37M 0.3%
17,310
+800
+5% +$67.1K
UNP icon
70
Union Pacific
UNP
$174B
$1.34M 0.29%
5,316
+300
+6% +$71.1K
INGR icon
71
Ingredion
INGR
$6.27B
$1.29M 0.28%
13,400
-2,025
-13% -$195K
VO icon
72
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$1.25M 0.27%
19,600
AFL icon
73
Aflac
AFL
$64.9B
$1.21M 0.27%
20,763
PEP icon
74
PepsiCo
PEP
$190B
$1.15M 0.25%
6,600
INMD icon
75
InMode
INMD
$870M
$1.14M 0.25%
16,200

Similar funds

EagleClaw Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, EagleClaw Capital Management held 146 positions worth $456M, up 18% from $388M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

EagleClaw Capital Management deployed $32.6M of net new capital in Q4 2021, opening 10 new positions and adding to 59 existing holdings. Its largest new stake was eBay: 75,000 shares worth $75K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2M trimmed.

  • EagleClaw Capital Management's largest Q4 2021 buy was eBay: 75,000 shares worth $75K.
  • EagleClaw Capital Management added most to Nike in Q4 2021, an estimated $16.1M increase.
  • EagleClaw Capital Management's biggest Q4 2021 reduction was Gilead Sciences, cutting an estimated $2M.
  • EagleClaw Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $467K.
  • EagleClaw Capital Management's ten largest holdings make up 37% of its $456M portfolio in Q4 2021.
  • EagleClaw Capital Management opened 10 new positions and closed 4 in Q4 2021.
  • EagleClaw Capital Management's portfolio value rose 18% quarter-over-quarter to $456M.

Based on EagleClaw Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.